文献速递冠心病外科

冠状动脉旁路移植术后新发心房颤动的发生率被低估及其对30天死亡率的影响

Underestimation of the incidence of new-onset post-coronary artery bypass grafting atrial fibrillation and its impact on 30-day mortality.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-06-13

该研究评估了9268例无术前房颤的孤立性冠状动脉旁路移植术患者,发现仅以「需治疗」定义术后房颤会显著低估其发生率(实际33.4% vs STS记录27.0%),且被漏录的房颤患者30天死亡风险显著升高(OR 2.08)。

要点

  • 术后房颤实际发生率33.4%,STS仅记录27.0%,漏录6.4%。
  • 漏录的术后房颤患者30天死亡风险显著增加(OR 2.08)。
  • 美国每年约9600例患者因此增高的死亡风险被遗漏。

核心结论

  • 将冠状动脉旁路移植术后房颤定义为需治疗的事件会显著低估其发生率并遗漏死亡风险显著增加的患者。

研究设计与样本

  • 多中心回顾性队列研究,纳入5家美国医院2004至2010年9268例连续无术前房颤的孤立性冠状动脉旁路移植术患者。

主要发现

  • 风险校正后术后房颤发生率为33.4%,其中STS数据记录27.0%,漏录6.4%。
  • 被STS数据漏录的术后房颤患者30天死亡风险显著高于被记录者(OR 2.08,95%CI 1.17-3.69)。
  • 基于该低估程度(OR 0.78,95%CI 0.72-0.83)推算,美国每年约9600例(95%CI 9420-9780)患者承受此增高死亡风险。

关键数值与推荐

  • STS数据采用「需治疗的房颤/扑动」定义。
  • 术后房颤通过连续院内心电图/遥测监测检出。

临床怎么用

  • 临床应重视连续监测检出的所有术后房颤事件,而非仅限需治疗者,以识别高危患者。

局限性

  • 原文未报告长期结局及治疗管理差异是否介导该风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Inconsistent definitions of atrial fibrillation after coronary artery bypass grafting have caused uncertainty about its incidence and risk. We examined the extent to which limiting the definition to post-coronary artery bypass grafting atrial fibrillation events requiring treatment underestimates its incidence and impact on 30-day mortality. METHODS: We assessed in-hospital atrial fibrillation and 30-day mortality in 9268 consecutive patients without preoperative atrial fibrillation who underwent isolated coronary artery bypass grafting at 5 US hospitals (2004-2010). Patients who experienced 1 or more episode of post-coronary artery bypass grafting atrial fibrillation detected via continuous in-hospital electrocardiogram/telemetry monitoring were divided into those for whom Society of Thoracic Surgeons data (applying the definition "atrial fibrillation/flutter requiring treatment") also indicated atrial fibrillation versus those for whom it did not. Risk-adjusted 30-day mortality was compared between these 2 groups and with patients without post-coronary artery bypass grafting atrial fibrillation. RESULTS: Risk-adjusted incidence of post-coronary artery bypass grafting atrial fibrillation incidence was 33.4% (27.0% recorded in Society of Thoracic Surgeons data, 6.4% missed). Patients with post-coronary artery bypass grafting atrial fibrillation missed by Society of Thoracic Surgeons data had a significantly greater risk of 30-day mortality (odds ratio, 2.08, 95% confidence interval, 1.17-3.69) than those captured. By applying the significant underestimation of post-coronary artery bypass grafting atrial fibrillation incidence we observed (odds ratio [Society of Thoracic Surgeons vs missed], 0.78; 95% confidence interval, 0.72-0.83) to the approximately 150,000 patients undergoing isolated coronary artery bypass grafting in the United States each year estimates this increased risk of mortality is carried by 9600 patients (95% confidence interval, 9420-9780) annually. CONCLUSIONS: Defining post-coronary artery bypass grafting atrial fibrillation as episodes requiring treatment significantly underestimates incidence and misses patients at a significantly increased risk for mortality. Further research is needed to determine whether this increased risk carries over into long-term outcomes and whether it is mediated by differences in treatment and management.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Filardo G, Pollock BD, da Graca B, et al. Underestimation of the incidence of new-onset post-coronary artery bypass grafting atrial fibrillation and its impact on 30-day mortality. J Thorac Cardiovasc Surg. 2017. PMID: 28697894. doi:10.1016/j.jtcvs.2017.05.104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。